UNSPSC 85502124: Supplement innominate artery with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement innominate artery with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03U237Z

UNSPSC 85502124 Supplement innominate artery with autologous tissue substitute, percutaneous approach is a Commodity code that describes a specific surgical procedure for vascular repair using autologous tissue grafting. Recent state and local opportunities tagged under this code show little activity aligned with the code's nominal medical procedure scope. The opportunities posted include independent medical evaluation services for disability pension determinations, surgical benefit carve-out network management for municipal employees, occupational medical surveillance for ferry workers, emergency and specialty healthcare services for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which involve performing or procuring innominate artery repair surgery. The mismatch suggests either systematic miscoding in state and local procurement systems or that this particular code has been applied as a catch-all for health services procurement despite its specificity to a defined surgical intervention. Issuers range across municipal retirement offices, county health systems, state transportation departments, county probation authorities, and county human resources divisions, with no repeat buyers evident in the available records.

The geographic spread of recent opportunities includes Arizona (City of Phoenix), California (City of Long Beach, County of Santa Clara), Washington State (Washington State Department of Transportation), Texas (Harris County), and Florida (Collier County), suggesting scattered multi-state activity rather than concentrated procurement. Representative recent opportunities include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026) and the Washington State Department of Transportation's RFP for occupational medical surveillance services (RFP20260825, due October 9, 2026). The code shows no recent solicitations for vascular surgical procedures, medical devices, or autologous tissue procurement aligned with its stated commodity definition, indicating low relevance for firms focused on surgical supply or vascular intervention services.